Clinical Trials Browser

Completed × INDUSTRY × rocakinogene sifuplasmid × Clear all

NCT03502785 2025-07-10

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Phase 1/2 Completed

35 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT02163057 2021-01-22

Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

Phase 1/2 Completed

22 enrolled 14 charts

Head & Neck

Head and Neck Squamous Cell Cancer

NCT02960594 2018-11-19

TRT-001

Phase 1 Completed

93 enrolled

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02241369 2018-11-16

Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies

Phase 1 Completed

3 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell, Neoplasms

NCT02514213 2017-12-26

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Phase 1 Completed

62 enrolled

Genitourinary

Prostatic Neoplasms